• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND EVOLUT FX DCS; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND EVOLUT FX DCS; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV Back to Search Results
Model Number D-EVOLUTFX-2329
Medical Device Problem Codes Failure to Advance (2524); Patient Device Interaction Problem (4001)
Health Effect - Clinical Code Aortic dissection (4870)
Date of Event 07/21/2025
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Continuation of d10: product id evfxplus-26 (serial: (b)(6)); product type: 0195-heart valves; implant date n/a; explant date n/a.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event or Problem Description
It was reported that during the attempted implant of a transcatheter valve, the delivery catheter system (dcs) was unable to advance through the ascending aorta.Subsequently, an abdominal aorta dissection extending to the aortic valve was observed, and the valve was never implanted.Per the physician, the patient's calcified anatomy contributed to the event.
 
Event or Problem Description
It was reported that during the attempted implant of a transcatheter valve, the delivery catheter system (dcs) was unable to advance through the ascending aorta.Subsequently, an abdominal aorta dissection extending to the aortic valve was observed, and the valve was never implanted.Per the physician, the patient's calcified anatomy contributed to the event.Additional information was received indicating that the dissection had been present prior to the procedure.Per the physician, neither the dcs nor the guidewire contributed to the dissection.The cause of the dissection is unknown.A balloon dilation was performed as intervention.
 
Additional Manufacturer Narrative
Updated data: a4.B2.B5.Added second paragraph.D4.H4.H6.Additional codes.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVOLUT FX DCS
Common Device Name
AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
EI 
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
EI  
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key22784583
Report Number9612164-2025-03942
Device Sequence Number12798156
Product Code NPT
UDI-Device Identifier00763000365684
UDI-Public(01)00763000365684(17)270528(10)0012840423
Combination Product (Y/N)N
Initial Reporter StateOK
Initial Reporter CountryUS
PMA/510(K) Number
P130021
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 09/10/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model NumberD-EVOLUTFX-2329
Device Catalogue NumberD-EVOLUTFX-2329
Device Lot Number0012840423
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 07/21/2025
Supplement Date Received by Manufacturer08/13/2025
Initial Report FDA Received Date08/12/2025
Supplement Report FDA Received Date09/10/2025
Date Device Manufactured05/28/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
SEE H11.
Outcome Attributed to Adverse Event Life Threatening; Required Intervention;
Patient Age64 YR
Patient SexMale
Patient Weight154 KG
-
-